Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB

Silke Feuerriegel, Thomas A. Kohl, Christian Utpatel, Sönke Andres, Florian P. Maurer, Jan Heyckendorf, Agathe Jouet, Nelly Badalato, Lynda Foray, Rashidatu Fouad Kamara, Osman S. Conteh, Philip Supply, Stefan Niemann
European Respiratory Journal 2020; DOI: 10.1183/13993003.01796-2020
Silke Feuerriegel
1Molecular and Experimental Mycobacteriology, Research Centre Borstel, Borstel, Germany
2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Kohl
1Molecular and Experimental Mycobacteriology, Research Centre Borstel, Borstel, Germany
2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas A. Kohl
Christian Utpatel
1Molecular and Experimental Mycobacteriology, Research Centre Borstel, Borstel, Germany
2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sönke Andres
3National and WHO Supranational Reference Centre for Mycobacteria, Research Centre Borstel, Borstel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian P. Maurer
3National and WHO Supranational Reference Centre for Mycobacteria, Research Centre Borstel, Borstel, Germany
4Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Florian P. Maurer
Jan Heyckendorf
2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
5Clinical Infectious Diseases, Research Centre Borstel, Borstel, Germany
6International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Heyckendorf
Agathe Jouet
7Genoscreen, Campus de l'Institut Pasteur de Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nelly Badalato
7Genoscreen, Campus de l'Institut Pasteur de Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nelly Badalato
Lynda Foray
8National Tuberculosis Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rashidatu Fouad Kamara
8National Tuberculosis Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osman S. Conteh
9National Reference Laboratory, Lakka Government Hospital, Freetown, Sierra Leone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Supply
10Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
11Philip Supply and Stefan Niemann contributed equally to the study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Niemann
1Molecular and Experimental Mycobacteriology, Research Centre Borstel, Borstel, Germany
2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
11Philip Supply and Stefan Niemann contributed equally to the study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sniemann@fz-borstel.de
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/13993003.01796-2020
PubMed 
32764113

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received May 1, 2020
  • Accepted June 24, 2020
  • Published online August 6, 2020.

Article Versions

  • You are currently viewing a previous version of this article (August 6, 2020 - 09:29).
  • View the most recent version of this article
Copyright & Usage 
Copyright ©ERS 2020

Author Information

  1. Silke Feuerriegel1,2,
  2. Thomas A. Kohl1,2,
  3. Christian Utpatel1,2,
  4. Sönke Andres3,
  5. Florian P. Maurer3,4,
  6. Jan Heyckendorf2,5,6,
  7. Agathe Jouet7,
  8. Nelly Badalato7,
  9. Lynda Foray8,
  10. Rashidatu Fouad Kamara8,
  11. Osman S. Conteh9,
  12. Philip Supply10,11 and
  13. Stefan Niemann1,2,11⇑
  1. 1Molecular and Experimental Mycobacteriology, Research Centre Borstel, Borstel, Germany
  2. 2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
  3. 3National and WHO Supranational Reference Centre for Mycobacteria, Research Centre Borstel, Borstel, Germany
  4. 4Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
  5. 5Clinical Infectious Diseases, Research Centre Borstel, Borstel, Germany
  6. 6International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany
  7. 7Genoscreen, Campus de l'Institut Pasteur de Lille, Lille, France
  8. 8National Tuberculosis Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone
  9. 9National Reference Laboratory, Lakka Government Hospital, Freetown, Sierra Leone
  10. 10Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
  11. 11Philip Supply and Stefan Niemann contributed equally to the study
  1. Stefan Niemann, Molecular and Experimental Mycobacteriology, Research Centre Borstel, 23845 Borstel, Germany. E-mail: sniemann{at}fz-borstel.de
View Full Text

Funding

  • European Commission

    FP7- 278864
  • Deutsches Zentrum für Infektionsforschung

  • Joachim Herz Stiftung

  • Leibniz Science Campus Evolutionary Medicine of the LUNG

  • Deutsche Forschungsgemeinschaft

    Precision Medicine in Chronic Inflammation EXC 216

Article usage

Article usage: August 2020 to December 2020

AbstractFullPdf
Aug 20208357061
Sep 20203563227
Oct 20202111813
Nov 20201451012
Dec 20201461612

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 1 Table of Contents
European Respiratory Journal: 57 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB
Silke Feuerriegel, Thomas A. Kohl, Christian Utpatel, Sönke Andres, Florian P. Maurer, Jan Heyckendorf, Agathe Jouet, Nelly Badalato, Lynda Foray, Rashidatu Fouad Kamara, Osman S. Conteh, Philip Supply, Stefan Niemann
European Respiratory Journal Jan 2020, 2001796; DOI: 10.1183/13993003.01796-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB
Silke Feuerriegel, Thomas A. Kohl, Christian Utpatel, Sönke Andres, Florian P. Maurer, Jan Heyckendorf, Agathe Jouet, Nelly Badalato, Lynda Foray, Rashidatu Fouad Kamara, Osman S. Conteh, Philip Supply, Stefan Niemann
European Respiratory Journal Jan 2020, 2001796; DOI: 10.1183/13993003.01796-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
  • Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
  • Residential air pollution increases the risk for persistent pulmonary hypertension after pulmonary endarterectomy
Show more Research letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society